Triumph Science & Technology Co.,Ltd (SHA:600552)
China · Delayed Price · Currency is CNY 15.02
+1.37 (10.04%)
Apr 17, 2026, 3:00 PM CST
SHA:600552 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,764 | 4,684 | 4,855 | 4,570 | 6,670 |
Other Revenue | 115.48 | 209.72 | 155.26 | 149.02 | 77.84 |
| 5,880 | 4,894 | 5,010 | 4,719 | 6,748 | |
Revenue Growth (YoY) | 20.15% | -2.32% | 6.17% | -30.07% | 33.15% |
Cost of Revenue | 4,833 | 4,086 | 4,358 | 3,956 | 5,685 |
Gross Profit | 1,047 | 808 | 651.64 | 762.66 | 1,063 |
Selling, General & Admin | 373.94 | 342.77 | 324.54 | 297.55 | 316.67 |
Research & Development | 343.56 | 292.75 | 219.24 | 235.16 | 337.64 |
Other Operating Expenses | 29.71 | 7.92 | 29.35 | -64.71 | 39.25 |
Operating Expenses | 766.63 | 652.76 | 582.05 | 414.86 | 723.55 |
Operating Income | 280.59 | 155.24 | 69.58 | 347.8 | 339.25 |
Interest Expense | -118.47 | -97.02 | -94.31 | -130.22 | -131.89 |
Interest & Investment Income | 8.48 | 15.7 | 28.14 | 5.85 | 8.52 |
Currency Exchange Gain (Loss) | -6.39 | 11.11 | 20.88 | 12.9 | 3.37 |
Other Non Operating Income (Expenses) | -11.07 | -11.58 | -9.13 | 0.7 | -5.44 |
EBT Excluding Unusual Items | 153.15 | 73.45 | 15.15 | 237.02 | 213.8 |
Impairment of Goodwill | - | - | -4.08 | - | - |
Gain (Loss) on Sale of Investments | -0.09 | 0.3 | 0.06 | -1.64 | -2.51 |
Gain (Loss) on Sale of Assets | -0.46 | 4.77 | 23.65 | 41.37 | 0.2 |
Asset Writedown | - | -3.41 | - | -1.14 | - |
Other Unusual Items | 48.33 | 165.25 | 167.59 | - | 129.07 |
Pretax Income | 200.92 | 240.35 | 202.37 | 275.61 | 340.55 |
Income Tax Expense | 39.23 | 45.82 | 51.9 | 50.85 | 33.6 |
Earnings From Continuing Operations | 161.69 | 194.53 | 150.47 | 224.76 | 306.95 |
Minority Interest in Earnings | -33.02 | -54.37 | -43.28 | -83.03 | -91.78 |
Net Income | 128.67 | 140.16 | 107.19 | 141.74 | 215.17 |
Net Income to Common | 128.67 | 140.16 | 107.19 | 141.74 | 215.17 |
Net Income Growth | -8.20% | 30.75% | -24.37% | -34.13% | 78.15% |
Shares Outstanding (Basic) | 945 | 944 | 944 | 779 | 764 |
Shares Outstanding (Diluted) | 945 | 944 | 944 | 779 | 764 |
Shares Change (YoY) | 0.03% | 0.01% | 21.27% | 1.96% | -0.01% |
EPS (Basic) | 0.14 | 0.15 | 0.11 | 0.18 | 0.28 |
EPS (Diluted) | 0.14 | 0.15 | 0.11 | 0.18 | 0.28 |
EPS Growth | -8.22% | 30.75% | -37.64% | -35.39% | 78.18% |
Free Cash Flow | 90.25 | -867.74 | -579.54 | -7.38 | 335.44 |
Free Cash Flow Per Share | 0.10 | -0.92 | -0.61 | -0.01 | 0.44 |
Dividend Per Share | 0.050 | 0.050 | 0.050 | 0.050 | 0.100 |
Dividend Growth | - | - | - | -50.00% | 100.00% |
Gross Margin | 17.81% | 16.51% | 13.01% | 16.16% | 15.75% |
Operating Margin | 4.77% | 3.17% | 1.39% | 7.37% | 5.03% |
Profit Margin | 2.19% | 2.86% | 2.14% | 3.00% | 3.19% |
Free Cash Flow Margin | 1.54% | -17.73% | -11.57% | -0.16% | 4.97% |
EBITDA | 676.37 | 562.02 | 400.41 | 677.98 | 613.96 |
EBITDA Margin | 11.50% | 11.48% | 7.99% | 14.37% | 9.10% |
D&A For EBITDA | 395.78 | 406.78 | 330.83 | 330.18 | 274.71 |
EBIT | 280.59 | 155.24 | 69.58 | 347.8 | 339.25 |
EBIT Margin | 4.77% | 3.17% | 1.39% | 7.37% | 5.03% |
Effective Tax Rate | 19.53% | 19.06% | 25.65% | 18.45% | 9.87% |
Revenue as Reported | 5,880 | 4,894 | 5,010 | 4,719 | 6,748 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.